PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.
PreOmics has raised $15.3M in total funding. The most recent round was Series B. The last funding was announced in January 2022.
PreOmics's investors include HTGF (High-Tech Gruenderfonds), Bruker, EISMEA, Think.Health, TBA Tyrolean Business Angel.
PreOmics is headquartered in Martinsried, Germany.
PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.
PreOmics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PreOmics — Funding & Investors." VCBacked, January 19, 2022, https://www.vcbacked.co/company/preomics. Accessed August 15, 2026.
VCBacked. (2022). PreOmics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/preomics
{{cite web |title=PreOmics — Funding & Investors |url=https://www.vcbacked.co/company/preomics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated